CRVAF (CurveBeam AI) Other Stockholders Equity: $-0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CRVAF CurveBeam AI Ltd CRVAF
2 GF Score
Price $0.05
! 5 Warning Signs
View Full Analysis

What is CurveBeam AI Other Stockholders Equity?

CurveBeam AI CRVAF 2 Other Stockholders Equity is $-0.00 Mil as of Dec. 2025. GuruFocus rates CRVAF with a GF Score™ of 2/100. The stock has 5 warning signs investors should review.

CurveBeam AI's Other Stockholders Equity for the quarter that ended in Dec. 2025 was $-0.00 Mil.

CurveBeam AI's quarterly Other Stockholders Equity increased from Dec. 2024 ($-0.00 Mil) to Jun. 2025 ($0.00 Mil) but then declined from Jun. 2025 ($0.00 Mil) to Dec. 2025 ($-0.00 Mil).

CurveBeam AI's annual Other Stockholders Equity declined from Jun. 2023 ($0.00 Mil) to Jun. 2024 ($-0.00 Mil) but then increased from Jun. 2024 ($-0.00 Mil) to Jun. 2025 ($0.00 Mil).

CurveBeam AI Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for CurveBeam AI's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CurveBeam AI Other Stockholders Equity Chart

CurveBeam AI Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Other Stockholders Equity
0.00 0.00 0.00 -0.00 0.00

CurveBeam AI Semi-Annual Data
Jun21 Dec21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only 0.00 -0.00 -0.00 0.00 -0.00
CRVAF
2GF Score
CurveBeam AI Ltd CRVAF
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CurveBeam AI Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $-0.00 Mil mean?
CurveBeam AI (CRVAF) has a Other Stockholders Equity of $-0.00 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on CurveBeam AI and its competitors.
Is CurveBeam AI's Other Stockholders Equity too high?
CurveBeam AI's current Other Stockholders Equity is $-0.00 Mil. Overall, CurveBeam AI has a GF Score™ of 2/100, reflecting its overall financial health beyond just this single metric.
How does CurveBeam AI's Other Stockholders Equity compare to ABT and SYK?
CurveBeam AI's Other Stockholders Equity of $-0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on CurveBeam AI and its competitors. CurveBeam AI's current Other Stockholders Equity is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CurveBeam AI stock overvalued right now?
CurveBeam AI (CRVAF) has a current Other Stockholders Equity of $-0.00 Mil. The current Other Stockholders Equity is $-0.00 Mil. CurveBeam AI's overall GF Score™ is 2/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For CurveBeam AI (CRVAF), the current Other Stockholders Equity is $-0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CurveBeam AI Business Description

Other Exchanges CVB:Australia
Address 10 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the company's CT devices to assist in the clinical assessment. The company has one operating segment, being the research, design, manufacture and sale of cone beam CT imaging equipment for orthopaedic specialties, which includes the development, validation and preparation for commercialisation of a HRpQCT Medical Device and Software as a Service (SaaS) platform.
2GF Score

Get the complete analysis for CRVAF

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.05
Price